510(k) device
Navilas Laser System 577sl (156691)
Od-Os GmbH · Laser, Ophthalmic (HQF, Class II) · First FDA decision Oct 27, 2009, newest Oct 29, 2025GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "Navilas"
MAUDE reports
19
Brand "Navilas", since 2015
PubMed studies
61
Mentioning "Navilas"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K251772 · Decided Oct 29, 2025 · 141 days after receipt
Device type: Laser, Ophthalmic (HQF) · Ophthalmology
- NAVILAS LASER SYSTEM510(k)
K091064 · Decided Oct 27, 2009 · 196 days after receipt
Device type: Laser, Ophthalmic (HQF) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Navilas", any status and sponsor, newest update first.
- MacuTherm Performance Study in Patients With iAMDPivotal-lookingRecruiting
OD-OS MacuTherm GmbHNot on our public-company list
NCT07607496 · 240 participants (planned) · Start May 29, 2026 · Primary completion Dec 2027
Device: photothermal therapy; Sham treatment · For: Intermediate AMD
Sites: Detmold, Germany; Hanover, Germany; Lübeck, Germany · 10 sites in all
University Hospital, BordeauxAcademic, hospital or other
NCT05679180 · 0 participants · Start May 11, 2023 · Primary completion May 24, 2023
Device: micropulse laser · For: Central Serous Chorioretinopathy
- A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular EdemaPivotal-lookingCompleted
Palmetto Retina Center, LLCAcademic, hospital or other
NCT01934556 · 150 participants · Start Nov 2013 · Primary completion Apr 2017
Device: Guided Laser Photocoagulation · For: Diabetic Macular Edema
Sites: Beverly Hills, California; West Columbia, South Carolina; Houston, Texas
Odense University HospitalAcademic, hospital or other
NCT02554747 · 48 participants · Start Oct 2015 · Primary completion Dec 2017
Device: Navigated laser; Conventional laser · For: Diabetic Macular Oedema
Sites: Odense, Denmark
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navilas", and for the whole product code for context.
This brand
19 reports: 8 malfunction, 11 injury, 0 death
Whole product code HQF
1,026 reports: 790 malfunction, 231 injury, 0 death
Newest reports for this brand
3008252121-2026-00001 · Received Apr 1, 2026 · Event dated Mar 3, 2026
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Failure to Align; Insufficient Device Problem Information; Noise, Audible
Patient problem as coded: Retinal Injury
- NAVILAS LASER SYSTEMInjury
3008252121-2024-00012 · Received Sep 23, 2024 · Event dated May 19, 2020
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Retinal Injury; Visual Disturbances
- NAVILAS LASER SYSTEMMalfunction
3008252121-2024-00008 · Received Feb 17, 2024 · Event dated Dec 18, 2023
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Intermittent Continuity; Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NAVILAS LASER SYSTEMMalfunction
3008252121-2024-00009 · Received Feb 17, 2024 · Event dated Dec 19, 2023
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Intermittent Continuity; Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NAVILAS LASER SYSTEMMalfunction
3008252121-2024-00010 · Received Feb 17, 2024 · Event dated Jan 19, 2024
Device type: Powered Laser Surgical Instrument (GEX)
Device problem as coded: Intermittent Continuity; Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Navilas"[tiab]. The summary above synthesizes these.
- Optical Coherence Tomography Angiography-Navigated Laser Photocoagulation of Retinal Hemangioblastomas in Patients With von Hippel-Lindau Disease.
Laich Y, Farassat N, Grewing V, et al. · Transl Vis Sci Technol · 2024Research Support, Non-U.S. Gov't
- Comparison of conventional pattern and novel navigated panretinal photocoagulation in proliferative diabetic retinopathy.
Chhablani J, Mathai A, Rani P, et al. · Invest Ophthalmol Vis Sci · 2014Comparative Study, Multicenter Study
- Comparison of navigated laser and conventional single-spot laser system for induced pain during panretinal photocoagulation.
Polat O, Inan S, Baysal Z, et al. · Lasers Med Sci · 2020Comparative Study, Randomized Controlled Trial
- Navigated laser (navilas) therapy for choroidal neovascular and hyperpermeability pathologies.
Alshahrani ST, Ghazi NG · Retin Cases Brief Rep · 2015Case Reports
- Treatment of Patients with Central Serous Chorioretinopathy using Navigated Laser Photocoagulation.
Tesa J, ín M · Cesk Slov Oftalmol · 2025
- Comparison of pain experience and time required for pre-planned navigated peripheral laser versus conventional multispot laser in the treatment of diabetic retinopathy.
Amoroso F, Pedinielli A, Astroz P, et al. · Acta Diabetol · 2020Comparative Study
- [Navigated retinal laser therapy].
Kernt M, Ulbig M, Kampik A, et al. · Ophthalmologe · 2013English Abstract
- Comparison of pain scores between patients undergoing panretinal photocoagulation using navigated or pattern scan laser systems.
Inan UU, Polat O, Inan S, et al. · Arq Bras Oftalmol · 2016Comparative Study
- [First experiences with Navilas® 577s micropulse laser in the treatment of diabetic maculopathy].
Ecsedy M, Kovács I, Gergely R, et al. · Orv Hetil · 2020
- NAVILAS Laser System Focal Laser Treatment for Diabetic Macular Edema - One Year Results of a Case Series.
Jung JJ, Gallego-Pinazo1 R, Lleó-Pérez A, et al. · Open Ophthalmol J · 2013
- OCTA-guided navigated laser therapy for advanced macula neovascularization secondary to age related macular degeneration.
Amoroso F, Souied EH, Cohen SY, et al. · Eur J Ophthalmol · 2021
- Comparative Analysis of Pain and Duration in Panretinal Photocoagulation: Navilas Laser versus Conventional Laser in Proliferative Diabetic Retinopathy.
Karapapak M, Ozal E, Ermis S, et al. · Sisli Etfal Hastan Tip Bul · 2024
Other devices of this type
Also filed under product code HQF.
- Hyperion Ltk SystemSunrise Technologies, Inc. · PMA 2002
- Sunrise Technologies Hyperion(Tm) Holmium Laser System for Laser Thermal Keratoplasty (Ltk)Sunrise Technologies, Inc. · PMA 2001
- VISULAS greenCarl Zeiss Meditec · 510(k) 2023
- Iridex 810 LaserIridex Corporation · 510(k) 2022
- Ophthalmic Yag Laser System YC-200Nidek Co., Ltd. · 510(k) 2020
- PSLT with PASCAL Synthesis, PSLT with PASCAL Synthesis TwinStarTopcon Medical Laser Systems, Inc. · 510(k) 2018
- LightLas Multi-Wavelength Medical Laser SystemLightmed Corporation · 510(k) 2016
- Lightlas Family of Multi-Wavelength Medical Laser SystemLightmed Corp. · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.